V. Sonninen

1.2k total citations
45 papers, 848 citations indexed

About

V. Sonninen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, V. Sonninen has authored 45 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in V. Sonninen's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (14 papers) and Alzheimer's disease research and treatments (5 papers). V. Sonninen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (14 papers) and Alzheimer's disease research and treatments (5 papers). V. Sonninen collaborates with scholars based in Finland. V. Sonninen's co-authors include U. K. Rinne, T. Siirtola, M.-L. Savontaus, Markku T. Hyyppä, P. Riekkinen, R. J. Marttila, Hannu Kalimo, H. Lang, Hannu Laaksonen and Leo Paljärvi and has published in prestigious journals such as Nature, Neurology and Annals of Neurology.

In The Last Decade

V. Sonninen

38 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Sonninen Finland 19 442 260 172 106 92 45 848
F. Bracco Italy 16 804 1.8× 232 0.9× 161 0.9× 77 0.7× 116 1.3× 33 1.2k
Katarzyna Sieradzan United Kingdom 11 373 0.8× 567 2.2× 263 1.5× 109 1.0× 54 0.6× 22 917
Hiroshi Ishino Japan 18 340 0.8× 273 1.1× 383 2.2× 233 2.2× 84 0.9× 89 1.0k
Manuela Caracciolo Italy 17 541 1.2× 246 0.9× 143 0.8× 103 1.0× 42 0.5× 28 785
A. Friedman Poland 14 702 1.6× 227 0.9× 87 0.5× 82 0.8× 143 1.6× 45 973
T. Shibazaki Japan 17 454 1.0× 379 1.5× 84 0.5× 45 0.4× 24 0.3× 43 924
Andres Deik United States 16 379 0.9× 188 0.7× 140 0.8× 224 2.1× 82 0.9× 33 722
Claire A. Sheldon Canada 20 342 0.8× 300 1.2× 316 1.8× 69 0.7× 101 1.1× 45 1.0k
Oren Cohen Israel 18 563 1.3× 336 1.3× 209 1.2× 134 1.3× 35 0.4× 43 1.0k
Yoko Mochizuki Japan 19 463 1.0× 221 0.8× 206 1.2× 180 1.7× 61 0.7× 95 947

Countries citing papers authored by V. Sonninen

Since Specialization
Citations

This map shows the geographic impact of V. Sonninen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Sonninen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Sonninen more than expected).

Fields of papers citing papers by V. Sonninen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Sonninen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Sonninen. The network helps show where V. Sonninen may publish in the future.

Co-authorship network of co-authors of V. Sonninen

This figure shows the co-authorship network connecting the top 25 collaborators of V. Sonninen. A scholar is included among the top collaborators of V. Sonninen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Sonninen. V. Sonninen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alanen, A., Johan A. K. Suykens, Hannu Kalimo, Markku Komu, & V. Sonninen. (2009). Ultrasound, computed tomography and magnetic resonance imaging in myopathies: correlations with electromyography and histopathology. Acta Neurologica Scandinavica. 89(5). 336–346. 17 indexed citations
2.
Rinne, U. K., Paavo Riekkinen, V. Sonninen, & Hannu Laaksonen. (2009). BRAIN ACETYLCHOLINESTERASE IN PARKINSON'S DISEASE. Acta Neurologica Scandinavica. 49(2). 215–226. 6 indexed citations
3.
Rinne, U. K. & V. Sonninen. (2009). CATECHOLAMINES IN PARKINSON'S DISEASE. Acta Neurologica Scandinavica. 46(S43). 217–218.
4.
Sonninen, V., U. K. Rinne, R. J. Marttila, P.K. Mölsä, & I. Rautakorpi. (2009). HOMOVANILLIC ACID IN THE CEREBROSPINAL FLUID AS AN INDEX OF BRAIN DOPAMINE TURNOVER. Acta Neurologica Scandinavica. 65(S90). 64–65.
5.
Sonninen, V., M.-L. Savontaus, & Jarmo Oksi. (2009). Hereditary multi-infarct dementia Clinical, genetic and neuroradiological studies of one family. Acta Neurologica Scandinavica. 69(S98). 289–290.
6.
Rinne, U. K., V. Sonninen, & T. Siirtola. (2009). L-DOPA TREATMENT IN PARKINSON'S DISEASE. Acta Neurologica Scandinavica. 46(S43). 221–222.
7.
Halonen, Päivi, A. Alanen, Hannu Kalimo, et al.. (2006). Facioscapulohumeral Muscular Dystrophy. Humana Press eBooks. 106(17). 375–379. 1 indexed citations
8.
Kallio, Johanna, R. J. Marttila, U. K. Rinne, V. Sonninen, & Erkka Syvälahti. (1991). Debrisoquine oxidation in Parkinson's disease. Acta Neurologica Scandinavica. 83(3). 194–197. 22 indexed citations
9.
Kalimo, Hannu, Marja‐Liisa Savontaus, H. Lang, et al.. (1988). X‐Linked myopathy with excessive autophagy: A new hereditary muscle disease. Annals of Neurology. 23(3). 258–265. 88 indexed citations
10.
Sonninen, V. & M.-L. Savontaus. (1987). Hereditary Multi-Infarct Dementia. European Neurology. 27(4). 209–215. 67 indexed citations
11.
Rinne, U. K., T. Siirtola, & V. Sonninen. (1978). L-deprenyl treatment of on-off phenomena in Parkinson's disease. Journal of Neural Transmission. 43(3-4). 253–262. 52 indexed citations
12.
Marttila, R. J., U. K. Rinne, T. Siirtola, & V. Sonninen. (1977). Mortality of patients with parkinson's disease treated with levodopa. Journal of Neurology. 216(3). 147–153. 52 indexed citations
13.
Rinne, U. K., R. J. Marttila, & V. Sonninen. (1977). Brain Dopamine Turnover and the Relief of Parkinsonism. Archives of Neurology. 34(10). 626–629. 8 indexed citations
14.
Rinne, U. K., Hannu Laaksonen, Paavo Riekkinen, & V. Sonninen. (1974). Brain Glutamic Acid Decarboxylase Activity in Parkinson’s Disease. European Neurology. 12(1). 13–19. 37 indexed citations
15.
Kangasniemi, P, V. Sonninen, & U. K. Rinne. (1972). EXCRETION OF FREE AND CONJUGATED 5-HIAA AND VMA IN URINE AND CONCENTRATION OF 5-HIAA AND HVA IN CSF DURING MIGRAINE ATTACKS AND FREE INTERVALS. Headache The Journal of Head and Face Pain. 12(2). 62–65. 21 indexed citations
16.
Rinne, U. K., V. Sonninen, & T. Siirtola. (1972). Treatment of Parkinson's disease with l-DOPA and decarboxylase inhibitor. Journal of Neurology. 202(1). 1–20. 22 indexed citations
17.
Pekkarinen, A., U. K. Rinne, Raimo K. R. Salokangas, T. Siirtola, & V. Sonninen. (1972). Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.. PubMed. 51. 129–30. 1 indexed citations
18.
Rinne, U. K. & V. Sonninen. (1967). Urinary Excretion of 3,4-Dimethoxyphenylethylamine in Parkinson's Disease. Nature. 216(5114). 489–489. 7 indexed citations
19.
Rinne, U. K., Lauri V. Laitinen, & V. Sonninen. (1967). Excretion of Homovanillic and Vanilmandelic Acids Before and After Thalamotomy for Extrapyramidal Disorders. European Neurology. 153(5). 345–352. 3 indexed citations
20.
Rinne, U. K., V. Sonninen, & Heikki J. Helminen. (1967). Ultrastructural Alterations and Changes in the Catecholamine Content of the Neurosecretory Nerve Endings in the Median Eminence of the Rat after Oxypertine Injection. Pharmacology. 17(2). 108–118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026